Evaluation of a Coated-Tube Assay for Antithyrotropin Receptor Antibodies in Patients with Graves' Disease and Other Thyroid Disorders

Thyroid

Volumn 14, Issue 4, 2004, Pages 295-300

  Cardia, Maria Silvia ^a   Lima, Nicolau ^a   Knobel, Meyer ^a   Medeiros Neto, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; THYROID DISEASE; TREATMENT OUTCOME;

AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; GRAVES DISEASE; HUMANS; MALE; RECEPTORS, THYROTROPIN; REFERENCE VALUES; THYROID DISEASES; THYROXINE;

EID: 2342642192     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504323030951     Document Type: Article

References (29)

1. Rees-Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121.
2. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 15:788-830.
3. Rees-Smith B 2001 Thyroid autoantibodies. Scan J Clin Lab Invest 61:45-52.
4. Prummel MF 2000 Graves' ophthalmopathy: diagnosis and management. Eur J Nucl Med 27:373-376.
5. Southgate K, Greagh F, Teece M, Kingswood C, Rees-Smith B 1984 A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf) 20:539-548.
6. Rees-Smith B, Rickards CR, Davies-Jones E, Kajita Y, Buckland PR, Creagh FM, Howells RD, Hashim F, Parkes AB, Petersen VB 1985 The thyrotropin receptor and its role in Graves' disease. J Endocrinol Invest 8:175-182.
7. Gupta MK 1992 Thyrotropin receptor antibodies: Advances and importance of detection techniques in thyroid diseases. Clin Biochem 25:193-199.
8. Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK 1992 Evaluation of serum basal thyrotropin levels and thyrotropin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease. Clin Endocrinol (Oxf) 36:585-590.
9. Edan G, Massart C, Hody B, Poirier JY, Le Reun M, Hespel JP, Leclech G, Simon M 1989 Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease. BMJ 298:359-361.
10. Kasagi K, Tamai H, Morita T, Hidaka A, Hatabu H, Misaki T, Iida Y, Ishihara T, Ikekubo K, Kuma K, et al. 1989 Role of thyrotropin receptor antibodies in the development of hyperthyroidism: Follow-up of nine patients with Graves' disease. J Clin Endocrinol Metab 68:1189-1194.
11. Feldt-Rasmussen U, Schleusener H, Carayon P 1994 Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long-term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 78:98-102.
12. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor interaction with TSH and autoantibodies. Endocr Rev 19:673-716.
13. Giovanella L, Ceriani L, Garancini S 2001 Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test. Clin Chem Lab Med 39:25-28.
14. Giovanella L, Ceriani L, Garancini S 2001 Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. J Nucl Med 15:115-119.
15. Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P 2001 TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: A comparison of two competitive binding assays. Clin Endocrinol (Oxf) 55:381-390.
16. Zimmermann-Belsing T, Nygaard B, Rasmussen AK, Feldt-Rasmussen U 2002 Use of the 2nd generation TRAb human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. Eur J Endocrinol 146:173-177.
17. Costagliola S, Swillens S, Niccoli P, Dumont JE, Vassart G, Ludgate M 1992 Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein. J Clin Endocrinol Metab 75:1540-1544.
18. Ilicki A, Gamstedt A, Karlsson FA 1992 Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 74:1090-1094.
19. Maugendre D, Massart C 2001 Clinical value of a new TSH binding inhibitory activity assay using human TSH receptors in the follow-up of anti-thyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clin Endocrinol (Oxf) 54:89-96.
20. Zophel K, Wunderlich G, Koch R, Franke WG 2000 Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease. Nuklearmedizin 39:113-120.
21. Morgenthaler NG, Hagata A, Katayama S, Bergmann A, Iitaka M 2002 Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor. Clin Endocrinol (Oxf) 57:193-198.
22. 125I-labeled TSH receptor. J Clin Endocrinol Metab 84:3797-3802.
23. Bolton J, Sanders J, Oda Y, Chapman C, Konno R, Furmaniak J, Rees-Smith B 1999 Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 45:2285-2287.
24. Kamijo K 2003 TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroditis: A comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 50:113-116.
25. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R 2001 Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res 33:504-507.
26. Tonacchera M, Vitti P, Agretti P, Giulianetti B, Mazzi B, Cavaliere R, Ceccarini G, Fiore E, Viacava P, Naccarato A, Pinchera A, Chiovato L 1998 Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid 8:559-564.
27. Kung AW, Lau KS, Kohn LD 2000 Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Thyroid 10:909-917.
28. Wallaschofski H, Muller D, Georgi P, Paschke R 2002 Induction of TSH-receptor antibodies in patients with toxic multinodular goiter by radioiodine treatment. Horm Metab Res 34:36-39.
29. 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82:2926-2930.